Courier Capital LLC Sells 225 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Courier Capital LLC reduced its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 2.6% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 8,337 shares of the financial services provider’s stock after selling 225 shares during the quarter. Courier Capital LLC’s holdings in iShares Biotechnology ETF were worth $1,214,000 at the end of the most recent quarter.

Several other hedge funds have also modified their holdings of the stock. Blue Fin Capital Inc. grew its stake in shares of iShares Biotechnology ETF by 0.7% during the second quarter. Blue Fin Capital Inc. now owns 10,516 shares of the financial services provider’s stock valued at $1,443,000 after purchasing an additional 74 shares during the last quarter. Security National Bank of SO Dak grew its stake in shares of iShares Biotechnology ETF by 0.7% during the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock valued at $1,436,000 after purchasing an additional 75 shares during the last quarter. SPC Financial Inc. grew its stake in shares of iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock valued at $475,000 after purchasing an additional 75 shares during the last quarter. Werba Rubin Papier Wealth Management grew its stake in shares of iShares Biotechnology ETF by 2.7% during the third quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after purchasing an additional 76 shares during the last quarter. Finally, Main Street Financial Solutions LLC grew its stake in shares of iShares Biotechnology ETF by 1.0% during the second quarter. Main Street Financial Solutions LLC now owns 8,002 shares of the financial services provider’s stock valued at $1,098,000 after purchasing an additional 82 shares during the last quarter. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

IBB opened at $142.16 on Thursday. iShares Biotechnology ETF has a one year low of $111.83 and a one year high of $150.57. The company’s 50 day simple moving average is $145.69 and its 200-day simple moving average is $139.92.

iShares Biotechnology ETF Announces Dividend

The firm also recently disclosed a dividend, which was paid on Monday, September 30th. Shareholders of record on Wednesday, September 25th were paid a $0.2005 dividend. The ex-dividend date of this dividend was Wednesday, September 25th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.